Paper Review Records
全部论文审稿周期
10 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
68
天
Automated expansion of iPSCs enables scalable extracellular vesicle production with anti-senescence bioactivity
作者
Toshihiko Nambara; Tammee M. Parsons; Ana-Caroline Raulin; Angelica Gaona; Bhaskar Roy; Takahisa Kanekiyo展开收起
作者单位
Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA展开收起
81
天
Higher yields of Vγ9Vδ2 T cells from peripheral blood than umbilical cord blood via interleukin-12 and interleukin-18
作者
Shih-Feng Cho; Wan-En Liao; Yi-Chang Liu; Te-Fu Chan; Shian-Ren Lin; Chia-Chun Tu; Ya-Fang Cheng; Chih-Hao Fang; Yuan-Yuan Huang; Shiu-Lan Wang; Wan-Yu Lai; Yee Chao; Li-Tzong Chen; Jan-Mou Lee展开收起
作者单位
Division of Hematology and Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, 80738, Taiwan; FullHope Biomedical Co. Ltd., New Taipei City, Taiwan; Department of Gynecology and Obstetrics, Kaohsiung Medical University Hospital, Kaohsiung, 80756, Taiwan; Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Medical University Hospital, and Center for Cancer Research and College of Medicine, Kaohsiung Medical University, Kaohsiung, 80738, Taiwan展开收起
148
天
Retrospective comparison of mesenchymal stromal cells and antithymocyte globulin as second-line therapy for acute graft-versus-host disease
作者
Makoto Murata; Seitaro Terakura; Junya Kanda; Naoyuki Uchida; Satoshi Yoshihara; Takahiro Fukuda; Keisuke Kataoka; Atsushi Wake; Noriko Doki; Shuichi Ota; Maho Sato; Masahito Tokunaga; Yasuo Mori; Hirohisa Nakamae; Moeko Hino; Makoto Onizuka; Ken Tabuchi; Yoshiko Atsuta; Takanori Teshima展开收起
作者单位
Department of Hematology, Shiga University of Medical Science, Otsu, Japan; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan; Department of Hematology, Kyoto University, Kyoto, Japan; Department of Hematology, Toranomon Hospital, Tokyo, Japan; Department of Hematology, Hyogo Medical University Hospital, Nishinomiya, Japan; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan; Department of Hematology, Toranomon Hospital, Kajigaya Kawasaki, Tokyo, Japan; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan; Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan; Department of Hematology/Oncology, Osaka Women’s and Children’s Hospital, Izumi, Japan; Department of Hematology, Imamura General Hospital, Kagoshima, Japan; Hematology, Oncology & Cardiovascular medicine, Kyushu University Hospital, Fukuoka, Japan; Department of Hematology, Osaka Metropolitan University Hospital, Osaka, Japan; Department of Pediatrics, School of Medicine, Chiba University, Chiba, Japan; Department of Hematology/Oncology, Tokai University School of Medicine, Isehara, Japan; Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan; Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan展开收起
148
天
MSC-delivered high-affinity variants of soluble PD1 lead to tumor regression
作者
Serap Gokcen; Tianyuan Chu; Phoebe Elizabeth Blair; Natalia Magdalena Krajewska; Greg Nicholas Brooke; Stuart Rushworth; Philippe Pierre Laissue; Ralf Michael Zwacka; Andrea Mohr展开收起
作者单位
School of Life Sciences, Protein Structure and Mechanisms of Disease Group, Cancer and Stem Cell Biology Group, University of Essex, Colchester, UK; School of Life Sciences, Protein Structure and Mechanisms of Disease Group, Molecular Oncology Laboratory, University of Essex, Colchester, UK; Metabolic Health Research Centre, Norwich Medical School, University of East Anglia, Norwich, UK; School of Life Sciences, Bioimaging Facility, University of Essex, Colchester, UK展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天